Correction: Preoperative chemoradiotherapy for rectal cancer: the sensitizer role of the association between miR-375 and c-Myc

Raquel Conde-Muiño; Carlos Cano; Victoria Sánchez-Martín; Antonio Herrera-Merchan; Ana Comino; Pedro P. Medina; Pablo Palma; Marta Cuadros

doi:10.18632/oncotarget.27541

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Preoperative chemoradiotherapy for rectal cancer: the sensitizer role of the association between miR-375 and c-Myc

PDF | How to cite

Oncotarget. 2020; 11:1202-1202. https://doi.org/10.18632/oncotarget.27541

Metrics: PDF 1273 views | ?

Raquel Conde-Muiño^1,*, Carlos Cano^2,*, Victoria Sánchez-Martín^3,4, Antonio Herrera-Merchan^4,5, Ana Comino¹, Pedro P. Medina^4,5, Pablo Palma^1,* and Marta Cuadros^3,4,*

¹ Division of Colon & Rectal Surgery, University Hospital Virgen de las Nieves, Granada, Spain
² Department of Computer Science and Artificial Intelligence, University of Granada, Granada, Spain
³ Department of Biochemistry, Molecular Biology III and Immunology, University of Granada, Granada, Spain
⁴ GENYO, Centre for Genomics and Oncological Research, Pfizer/University of de Granada/Junta de Andalucía, PTS Granada, Granada, Spain
⁵ Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain
^* These authors have contributed equally to this work

Published: March 31, 2020

This article has been corrected: The name of the 4th author in the listing has been updated, correcting the name as follows:

Antonio Herrera-Merchan^4,5

Original article: Oncotarget. 2017; 8:82294–82302. DOI: https://doi.org/10.18632/oncotarget.19393.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 27541

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: Preoperative chemoradiotherapy for rectal cancer: the sensitizer role of the association between miR-375 and c-Myc